In colorectal cancer, REG3A forms an RNA–DNA triplex with lncRNA REG1CP to promote cancer cell-cycle progression and tumorigenicity and is associated with poor patient outcomes [67]. This evidence concerns the gene REG3A and colorectal cancer.